Subjects who receive the Treovance stent-graft for Abdominal Aortic Aneurysm
This trial is testing a new stent-graft for people with abdominal aortic aneurysms. They want to see if it's safe and effective.
- Abdominal Aortic Aneurysm
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Will this research be conducted with elderly participants?
"Eligibility for this particular clinical trial is restricted to patients that are between 18 and 85 years old. In contrast, there are 8 trials that are only enrolling patients below the age of eighteen and 158 studies recruiting participants above 65."
At how many locations is this research being conducted?
"The trial is based in University of Iowa Hospital and Clinic, situated in Iowa City, with other locations in University of Alabama-Birmingham, Birmingham, Arizona Heart Institute in Phoenix as well as 32 other sites."
Are there any more spots left for people who want to participate in this research project?
"From the information on clinicaltrials.gov, it can be gathered that this trial is not presently looking for patients. This trial was initially posted on 11/23/2013 and was last updated on 6/25/2020; however, there are 160 other trials enrolling patients at this time."
Could I qualify to be a subject in this clinical trial?
"Aneurysm patients who are between 18 and 85 years old may be eligible for this study. Up to 150 people can participate."
Does the Treovance stent-graft have FDA approval for use in human subjects?
"This is a Phase 2 trial, which means that while there are safety data, there are no efficacy data. Therefore, the Power team gave it a rating of 2."